Patient Safety Organizations: Voluntary Relinquishment for the Chicago Breast Cancer Quality Consortium
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to list as a patient safety organization (PSO) an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be "delisted" by the Secretary if it is found to no longer meet the requirements of the Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO's listing expires. AHRQ accepted a notification of proposed voluntary relinquishment from the Chicago Breast Cancer Quality Consortium, PSO number P0074, of its status as a PSO, and has delisted the PSO accordingly.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 185 (Tuesday, September 28, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 185 (Tuesday, September 28, 2021)]
[Notices]
[Pages 53658-53659]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-21072]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Relinquishment for the
Chicago Breast Cancer Quality Consortium
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services (HHS).
ACTION: Notice of delisting.
-----------------------------------------------------------------------
SUMMARY: The Patient Safety and Quality Improvement Final Rule (Patient
Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to
list as a patient safety organization (PSO) an entity that attests that
it meets the statutory and regulatory requirements for listing. A PSO
can be ``delisted'' by the Secretary if it is found to no longer meet
the requirements of the Patient Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses
to voluntarily relinquish its status as a PSO for any reason, or when a
PSO's listing expires. AHRQ accepted a notification of proposed
voluntary relinquishment from the Chicago Breast Cancer Quality
Consortium, PSO number P0074, of its status as a PSO, and has delisted
the PSO accordingly.
DATES: The delisting was effective at 12:00 Midnight ET (2400) on
September 14, 2021.
ADDRESSES: The directories for both listed and delisted PSOs are
ongoing and reviewed weekly by AHRQ. Both directories can be accessed
electronically at the following HHS website: <a href="http://www.pso.ahrq.gov/listed">http://www.pso.ahrq.gov/listed</a>.
FOR FURTHER INFORMATION CONTACT: Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, MS 06N100B,
Rockville, MD 20857; Telephone (toll free): (866) 403-3697; Telephone
(local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local):
(301) 427-1130; Email: <a href="/cdn-cgi/l/email-protection#a5d5d6cae5c4cdd7d48bcdcdd68bc2cad3"><span class="__cf_email__" data-cfemail="a8d8dbc7e8c9c0dad986c0c0db86cfc7de">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
[[Page 53659]]
Background
The Patient Safety Act, 42 U.S.C. 299b-21 to 299b-26, and the
related Patient Safety Rule, 42 CFR part 3, published in the Federal
Register on November 21, 2008 (73 FR 70732-70814), establish a
framework by which individuals and entities that meet the definition of
provider in the Patient Safety Rule may voluntarily report information
to PSOs listed by AHRQ, on a privileged and confidential basis, for the
aggregation and analysis of patient safety work product.
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
are to conduct activities to improve patient safety and the quality of
health care delivery.
HHS issued the Patient Safety Rule to implement the Patient Safety
Act. AHRQ administers the provisions of the Patient Safety Act and
Patient Safety Rule relating to the listing and operation of PSOs. The
Patient Safety Rule authorizes AHRQ to list as a PSO an entity that
attests that it meets the statutory and regulatory requirements for
listing. A PSO can be ``delisted'' if it is found to no longer meet the
requirements of the Patient Safety Act and Patient Safety Rule, when a
PSO chooses to voluntarily relinquish its status as a PSO for any
reason, or when a PSO's listing expires. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of PSOs.
AHRQ has accepted a notification of proposed voluntary
relinquishment from the Chicago Breast Cancer Quality Consortium to
voluntarily relinquish its status as a PSO. Accordingly, the Chicago
Breast Cancer Quality Consortium, P0074, was delisted effective at
12:00 Midnight ET (2400) on September 14, 2021.
Chicago Breast Cancer Quality Consortium has patient safety work
product (PSWP) in its possession. The PSO will meet the requirements of
section 3.108(c)(2)(i) of the Patient Safety Rule regarding
notification to providers that have reported to the PSO and of section
3.108(c)(2)(ii) regarding disposition of PSWP consistent with section
3.108(b)(3). According to section 3.108(b)(3) of the Patient Safety
Rule, the PSO has 90 days from the effective date of delisting and
revocation to complete the disposition of PSWP that is currently in the
PSO's possession.
More information on PSOs can be obtained through AHRQ's PSO website
at <a href="http://www.pso.ahrq.gov">http://www.pso.ahrq.gov</a>.
Dated: September 23, 2021.
Marquita Cullom,
Associate Director.
[FR Doc. 2021-21072 Filed 9-27-21; 8:45 am]
BILLING CODE 4160-90-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.